Surgical Hemostatic Agents - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510249192

Publication Date:

October 30, 2024

Pages:

123

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Hemostasis, also known as hemorrhage prevention, is the process that stops blood from leaking into a blood vessel. Hemostasis happens when a clot develops at the location of the blood vessel injury, repairing it. This report mainly focuses on surgical hemostatic agents market.
The global market for Surgical Hemostatic Agents was estimated to be worth US$ 3975 million in 2023 and is forecast to a readjusted size of US$ 5746.2 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Surgical Hemostatic Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Surgical Hemostatic Agents by region & country, by Type, and by Application.
The Surgical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Hemostatic Agents.
麻豆原创 Segmentation
By Company
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
Segment by Type:
Gelation Hemostats
Combination Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Surgical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Surgical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Surgical Hemostatic Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Surgical Hemostatic Agents Product Introduction
1.2 Global Surgical Hemostatic Agents 麻豆原创 Size Forecast
1.2.1 Global Surgical Hemostatic Agents Sales Value (2019-2030)
1.2.2 Global Surgical Hemostatic Agents Sales Volume (2019-2030)
1.2.3 Global Surgical Hemostatic Agents Sales Price (2019-2030)
1.3 Surgical Hemostatic Agents 麻豆原创 Trends & Drivers
1.3.1 Surgical Hemostatic Agents Industry Trends
1.3.2 Surgical Hemostatic Agents 麻豆原创 Drivers & Opportunity
1.3.3 Surgical Hemostatic Agents 麻豆原创 Challenges
1.3.4 Surgical Hemostatic Agents 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Surgical Hemostatic Agents Players Revenue Ranking (2023)
2.2 Global Surgical Hemostatic Agents Revenue by Company (2019-2024)
2.3 Global Surgical Hemostatic Agents Players Sales Volume Ranking (2023)
2.4 Global Surgical Hemostatic Agents Sales Volume by Company Players (2019-2024)
2.5 Global Surgical Hemostatic Agents Average Price by Company (2019-2024)
2.6 Key Manufacturers Surgical Hemostatic Agents Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Surgical Hemostatic Agents Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Surgical Hemostatic Agents
2.9 Surgical Hemostatic Agents 麻豆原创 Competitive Analysis
2.9.1 Surgical Hemostatic Agents 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Surgical Hemostatic Agents Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostatic Agents as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gelation Hemostats
3.1.2 Combination Hemostats
3.1.3 Others
3.2 Global Surgical Hemostatic Agents Sales Value by Type
3.2.1 Global Surgical Hemostatic Agents Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Surgical Hemostatic Agents Sales Value, by Type (2019-2030)
3.2.3 Global Surgical Hemostatic Agents Sales Value, by Type (%) (2019-2030)
3.3 Global Surgical Hemostatic Agents Sales Volume by Type
3.3.1 Global Surgical Hemostatic Agents Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Surgical Hemostatic Agents Sales Volume, by Type (2019-2030)
3.3.3 Global Surgical Hemostatic Agents Sales Volume, by Type (%) (2019-2030)
3.4 Global Surgical Hemostatic Agents Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Surgical Centers
4.1.3 Other
4.2 Global Surgical Hemostatic Agents Sales Value by Application
4.2.1 Global Surgical Hemostatic Agents Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Surgical Hemostatic Agents Sales Value, by Application (2019-2030)
4.2.3 Global Surgical Hemostatic Agents Sales Value, by Application (%) (2019-2030)
4.3 Global Surgical Hemostatic Agents Sales Volume by Application
4.3.1 Global Surgical Hemostatic Agents Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Surgical Hemostatic Agents Sales Volume, by Application (2019-2030)
4.3.3 Global Surgical Hemostatic Agents Sales Volume, by Application (%) (2019-2030)
4.4 Global Surgical Hemostatic Agents Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Surgical Hemostatic Agents Sales Value by Region
5.1.1 Global Surgical Hemostatic Agents Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Surgical Hemostatic Agents Sales Value by Region (2019-2024)
5.1.3 Global Surgical Hemostatic Agents Sales Value by Region (2025-2030)
5.1.4 Global Surgical Hemostatic Agents Sales Value by Region (%), (2019-2030)
5.2 Global Surgical Hemostatic Agents Sales Volume by Region
5.2.1 Global Surgical Hemostatic Agents Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Surgical Hemostatic Agents Sales Volume by Region (2019-2024)
5.2.3 Global Surgical Hemostatic Agents Sales Volume by Region (2025-2030)
5.2.4 Global Surgical Hemostatic Agents Sales Volume by Region (%), (2019-2030)
5.3 Global Surgical Hemostatic Agents Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Surgical Hemostatic Agents Sales Value, 2019-2030
5.4.2 North America Surgical Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Surgical Hemostatic Agents Sales Value, 2019-2030
5.5.2 Europe Surgical Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Surgical Hemostatic Agents Sales Value, 2019-2030
5.6.2 Asia Pacific Surgical Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Surgical Hemostatic Agents Sales Value, 2019-2030
5.7.2 South America Surgical Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Surgical Hemostatic Agents Sales Value, 2019-2030
5.8.2 Middle East & Africa Surgical Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Surgical Hemostatic Agents Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Surgical Hemostatic Agents Sales Value
6.2.1 Key Countries/Regions Surgical Hemostatic Agents Sales Value, 2019-2030
6.2.2 Key Countries/Regions Surgical Hemostatic Agents Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Surgical Hemostatic Agents Sales Value, 2019-2030
6.3.2 United States Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Surgical Hemostatic Agents Sales Value, 2019-2030
6.4.2 Europe Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Surgical Hemostatic Agents Sales Value, 2019-2030
6.5.2 China Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.5.3 China Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Surgical Hemostatic Agents Sales Value, 2019-2030
6.6.2 Japan Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Surgical Hemostatic Agents Sales Value, 2019-2030
6.7.2 South Korea Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Surgical Hemostatic Agents Sales Value, 2019-2030
6.8.2 Southeast Asia Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Surgical Hemostatic Agents Sales Value, 2019-2030
6.9.2 India Surgical Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.9.3 India Surgical Hemostatic Agents Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 J&J
7.1.1 J&J Company Information
7.1.2 J&J Introduction and Business Overview
7.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.1.4 J&J Surgical Hemostatic Agents Product Offerings
7.1.5 J&J Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Surgical Hemostatic Agents Product Offerings
7.2.5 Baxter Recent Development
7.3 BD
7.3.1 BD Company Information
7.3.2 BD Introduction and Business Overview
7.3.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BD Surgical Hemostatic Agents Product Offerings
7.3.5 BD Recent Development
7.4 Gelita
7.4.1 Gelita Company Information
7.4.2 Gelita Introduction and Business Overview
7.4.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Gelita Surgical Hemostatic Agents Product Offerings
7.4.5 Gelita Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Information
7.5.2 Pfizer Introduction and Business Overview
7.5.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer Surgical Hemostatic Agents Product Offerings
7.5.5 Pfizer Recent Development
7.6 B Braun
7.6.1 B Braun Company Information
7.6.2 B Braun Introduction and Business Overview
7.6.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.6.4 B Braun Surgical Hemostatic Agents Product Offerings
7.6.5 B Braun Recent Development
7.7 CSL Behring
7.7.1 CSL Behring Company Information
7.7.2 CSL Behring Introduction and Business Overview
7.7.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CSL Behring Surgical Hemostatic Agents Product Offerings
7.7.5 CSL Behring Recent Development
7.8 Ferrosan Medical Devices
7.8.1 Ferrosan Medical Devices Company Information
7.8.2 Ferrosan Medical Devices Introduction and Business Overview
7.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Offerings
7.8.5 Ferrosan Medical Devices Recent Development
7.9 Advance Medical Solution
7.9.1 Advance Medical Solution Company Information
7.9.2 Advance Medical Solution Introduction and Business Overview
7.9.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Advance Medical Solution Surgical Hemostatic Agents Product Offerings
7.9.5 Advance Medical Solution Recent Development
7.10 Medtronic
7.10.1 Medtronic Company Information
7.10.2 Medtronic Introduction and Business Overview
7.10.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Medtronic Surgical Hemostatic Agents Product Offerings
7.10.5 Medtronic Recent Development
7.11 Z-Medica
7.11.1 Z-Medica Company Information
7.11.2 Z-Medica Introduction and Business Overview
7.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Z-Medica Surgical Hemostatic Agents Product Offerings
7.11.5 Z-Medica Recent Development
7.12 Marine Polymer
7.12.1 Marine Polymer Company Information
7.12.2 Marine Polymer Introduction and Business Overview
7.12.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Marine Polymer Surgical Hemostatic Agents Product Offerings
7.12.5 Marine Polymer Recent Development
7.13 Equimedical
7.13.1 Equimedical Company Information
7.13.2 Equimedical Introduction and Business Overview
7.13.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Equimedical Surgical Hemostatic Agents Product Offerings
7.13.5 Equimedical Recent Development
7.14 CryoLife
7.14.1 CryoLife Company Information
7.14.2 CryoLife Introduction and Business Overview
7.14.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.14.4 CryoLife Surgical Hemostatic Agents Product Offerings
7.14.5 CryoLife Recent Development
8 Industry Chain Analysis
8.1 Surgical Hemostatic Agents Industrial Chain
8.2 Surgical Hemostatic Agents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Surgical Hemostatic Agents Sales Model
8.5.2 Sales Channel
8.5.3 Surgical Hemostatic Agents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.